We are a group of medical professionals who advocate for addiction Medicine and Strive to:
Increase access to, and improve the quality of addiction treatment;
Educate physicians (including medical and ostepathic students), other healthcare providers, and the public;
Support research and prevention;
Promote the appropriate role of the physician in the care of patients with addictive disorders;
Establish addiction medicine as a primary speciality recognized by professional organizations, governments, physicians, purchasers and consumers of healthcare services and the general public.
FOR IMMEDIATE RELEASE
CHEVY CHASE, MD – The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the... Read More
FOR IMMEDIATE RELEASE
CHEVY CHASE, MD – The American Society of Addiction Medicine (ASAM) applauds last weeks announcement that Kimberly Johnson, PhD has been appointed to serve as the next Director of the Center for Substance Abuse Treatment (CSAT) within the Substance Abuse and Mental Health Services Administration (SAMHSA).
“ASAM has worked with Dr. Johnson and the national office that coordinates the Addiction Technology Transfer Center’s (ATTC) for a number of years,” said ASAM President Dr. Jeffrey Goldsmith. “Now as Director of CSAT, we look forward to her leadership and to the expansion of innovative and effective substance use disorder treatment services, programs and practices.”
Under Dr. Johnson's leadership, the national office of the Addiction Technology Transfer Centers (ATTC) is sponsoring a symposium at ASAM’s 47th Annual Conference – Innovations in Addiction Medicine and Science this April 14-17 in Baltimore, MD. The ASAM 47th Annual Conference is the largest gathering of addiction physicians, psychiatrists, clinicians, researchers and academicians who treat and help patients with substance use disorders.
ASAM looks forward to further partnering with Dr. Johnson and SAMSHA in her new role.
For more information about ASAM or The ASAM 47th Annual Conference – Innovations in Addiction Medicine and Science visit www.ASAM.org
# # #
Addiction medicine providers are being asked to help shape the future of the International Classification of Diseases (ICD). The World Health Organization is requesting input from physicians, nurses, insurers, public health professionals and policy-makers on the ICD-11, the next version of the disease classification system used around the...
<p>Leading the writing committee to draft the <a href="http://www.asam.org/docs/default-source/publicy-policy-statements/marijuana-cannabinoids-and-legalization-9-21-2015.pdf?sfvrsn=0" target="_blank">“ASAM Public Policy Statement on Marijuana, Cannabinoids and Legalization”</a> presented...
The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) are pleased to unveil new online toolkits designed for National Drug and Alcohol Facts WeekSM event holders interested in focusing on specific drugs. National Drug and Alcohol Facts......
Image courtesy of ADAPT Pharma, Inc. Easy-to-use technology provides alternative to injectable form of lifesaving medication The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, is pleased to announce that intranasal naloxone –a nasal spray formulation of the......